Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow to the company’s ambitions to...
A ground-breaking cancer therapy being tested in China is offering new hope for patients with advanced malignancies, particularly those who have exhausted conventional treatment...